Navigation Links
Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
Date:10/26/2008

chief scientific officer of Sequoia. "To address this need, we designed our protease inhibitor using a structure-based approach that targets highly conserved regions of the protease enzyme while minimizing interactions with regions of the enzyme that are highly malleable and thus susceptible to mutations."

First-in-human data with SPI-256

The primary objective of this Phase 1; randomized, double-blind, placebo-controlled, single- and escalating-dose crossover study was to evaluate the safety, tolerability and pharmacokinetics of single, ascending doses of SPI-256 administered alone or in combination with 100mg ritonavir (RTV) in healthy volunteers.

Data were presented on 59 healthy volunteers who took a single dose of SPI-256 (150mg, 450mg, 600mg, 900mg, or 1200mg) alone in Phase 1 of the study (n=38); in Phase 2 of the study, 37 subjects took either a single dose of SPI-256 (150mg, 450mg, 900mg) in combination with 100mg of RTV or received a single dose of 1200mg of SPI-256 with a high-fat meal.

SPI-256 demonstrated that it was generally safe and well tolerated in this healthy volunteer population. Adverse events (AEs) were reported by approximately half of subjects, although most were judged to be unrelated or unlikely to be related to study drug. In Phase 1 of the study, three subjects reported a total of 8 AEs possibly related to study drug. In Phase 2 of the study, two subjects reported one AE each that was possibly or definitely related to study drug.

Peak exposure to SPI-256 given alone was dose proportional over the range of 150 to 1200mg. In addition, a single dose of SPI-256 achieved sufficient plasma concentration to suggest the potential of once- or twice-daily dosing regimens in treatment-naive or -experienced patients.

When combined with ritonavir, SPI-256 levels were markedly elevated. This finding suggests that SPI-256 may be amenable to boosting with Sequoia's own pharmacokinetic enhancer, SPI-452, which is
'/>"/>

SOURCE Sequoia Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... and HOUSTON, TX , Feb. ... "Company") (TSX-V: EPI) and Bloom Burton & Co. Ltd. ... voluntary contractual lock-up (the "Lock-Up") 2,353,130 common shares of ... Shares originally subject to the Lock-Up. Of the Common ... free trading immediately upon release from the Lock-Up while ...
(Date:2/27/2015)... , Feb. 27, 2015   Synageva BioPharma Corp. ... biopharmaceutical company developing therapeutic products for rare diseases, ... the European Organisation for Rare Diseases™ (EURORDIS™), The ... in observing Rare Disease Day. On ... organizations, industry, and other participants conduct special events ...
(Date:2/27/2015)...  Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), ... 3D bioprinting technology, announced today that Keith ... present live at VirtualInvestorConferences.com on March 5th. ... for this Company update," said Mr. Murphy. "We ... of the exVive3D Liver, Bioprinted Human Tissue, commercialization ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4
... , SAN MATEO, Calif., Oct. 20 AlphaDetail, an ... two new features to its suite of tracking services: ... their competitive landscape by integrating secondary research with tracking ... today is managing through vast amounts of data, gathered ...
... 20 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced ... Investor Conference on Monday, October 26, 2009 at 5:00 p.m. ... at the Hyatt Regency La Jolla Hotel in San Diego. ... Anadys, will provide an overview of Anadys and its clinical ...
Cached Medicine Technology:AlphaDetail Tracking Study Enhancements: The Advantage of Integration and Speed 2Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences 2
(Date:2/28/2015)... AB (PRWEB) February 28, 2015 The ... is now a distributor of the machine. The Heart ... of their license, like a franchise model. The goal ... prevent and reverse heart disease. To buy External ... Fit Clinic can help individuals through this process and ...
(Date:2/28/2015)... Mew and Company, a Vancouver corporate tax accounting ... consulting services in addition to a variety of other ... planning. Company finances are a complicated matter that should ... this, complex Canadian tax laws can make it even ... Mew and Company works to advise their clients on ...
(Date:2/28/2015)... A study out of the University of ... for the treatment of a hereditary ocular condition that ... by Dr. Robert MacLaren, professor of ophthalmology at the ... Journal on January 16, 2014 , the study treated ... that mostly affects men and leads to the degeneration ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Pioneer Millworks ... 2015 Japan Architecture & Construction Materials Show, an annual, ... more than 1,000 suppliers and top manufacturers of the ... Reclaimed wood products sourced and manufactured by Pioneer ... found popularity in Japan at restaurants, hotels, retailers, and ...
(Date:2/28/2015)... 28, 2015 India Network Foundation, ... visitor health insurance programs for visitors coming to the ... elderly parents traveling to the United States are suffering ... and blood pressure. These diseases are so common among ... them as medical conditions. There were 66.8 million cases ...
Breaking Medicine News(10 mins):Health News:Clinicians Can Now Purchase External Counterpulsation with Heart Fit Clinic 2Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3
Statistics released by the Scottish Executive show that around 2.9 million clean needles were dispensed for drug users, but only 1.9 million were returned thus sparking a shortage of a million needles...
... become stagnant in our body result in Colon cancer. He received ... tissue cells can be damaged if the wastes are not removed ... cells become weak and unhealthy. One should have a bowel movement ... have shown that if you have a bowel movement every 3 ...
... Mouse population has been on the rise past two winters, ... field days for the scurrying mouse. Infact mouse proliferation has ... fallout of poor hygiene in mice habitats. ,Some ... fever, muscle aches, nausea, cough and abdominal pain, which surface ...
... it was appropriate for Rahul Mahajan to be taken to ... to Apollo hospital and not to AIIMS or Safdarjang even ... overdosing. //But medical experts say drug overdosed patients should be ... treated, the better are the chances of their survival. ...
... Melbourne University has launched a plan to improve the bedside ... effect, the medical students will be "embedded" with patients suffering ... two years. // ,This program will be compulsory ... Harvard Medical School in the US. "I think it would ...
... has been invited by non-resident Indians (NRIs) in Mauritius to tie ... be held June 18. // ,Ajeetpal Singh, who has a ... to tie 125 turbans or "safas" for a marriage ceremony. And ... hours. ,Singh plunged into this art at the age ...
Cached Medicine News:Health News:The myth about government hospitals 2
5L...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: